Reliance Pharma Fund - Direct (Bonus)

Fund Class : Equity - Pharma
Fund House : Reliance Mutual Fund
Aum(Rs Cr) : 653.56
NAV 22 Jun 2017 131.94 -0.56
(-0.42%)

NAV High-Low (in Rs)

ONE Mth 1235.15
1235.15
52-WEEk 1235.15
1615.51

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes - 0.98 - - 12.23
Sensex 0.26 2.55 19.58 15.32 24.4
Nifty -0.14 2.01 19.9 15.77 27.78

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 653.56 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 1.00.

Fund Activity

   As On 31 May 2017
Category Share (%)
Cash & Cash Equivalent 0.00
CBLO 2.20
Derivatives 0.24
Equity 98.98
› More
   As On 31 May 2017
Sector Name Amount
Finance & Investments 4.82
Healthcare 4.05
Miscellaneous 5.73
NA 2.44
Pharmaceuticals - Indian - Bulk Drugs 17.70
Pharmaceuticals - Indian - Bulk Drugs & Formln 49.17
Pharmaceuticals - Multinational 17.51
› More
   As On 31 May 2017
Company Name
Aurobindo Pharma 9.53
Divi's Lab. 9.43
Dr Reddy's Labs 9.21
Abbott India 9.14
Cadila Health. 8.64
Sanofi India 8.37
Lupin 8.27
Sun Pharma.Inds. 7.31
› More

Fund DETAILS

Asset Management Co.

Registered Address

Reliance Capital Asset Management Company,

One Indiabulls Centre Tower 1
12th Flr 841 Senapati Bapat
Marg Elphinstone Road Mumbai-400013

Phone: 022-30994600 | Fax: 022-30994699

Email: customer_care@reliancemutual.com

Website: www.reliancemutual.com